A 2007 American College of Physicians guideline addressed pharmacologic
options for low back pain. Now, new evidence and medications have now become
available.
The number of trials ranged from 9
(benzodiazepines) to 70 (nonsteroidal anti-inflammatory drugs). New
evidence found that acetaminophen was ineffective for acute low back
pain, nonsteroidal anti-inflammatory drugs had smaller benefits for
chronic low back pain than previously observed, duloxetine was effective
for chronic low back pain, and benzodiazepines were ineffective for
radiculopathy. For opioids, evidence remains limited to short-term
trials showing modest effects for chronic low back pain; trials were not
designed to assess serious harms. Skeletal muscle relaxants are
effective for short-term pain relief in acute low back pain but caused
sedation. Systemic corticosteroids do not seem to be effective. For
effective interventions, pain relief was small to moderate and generally
short-term; improvements in function were generally smaller. Evidence
is insufficient to determine the effects of antiseizure medications.
Literature:
Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, et al. Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. [Epub ahead of print 14 February 2017] doi: 10.7326/M16-2458
http://annals.org/aim/article/2603229/systemic-pharmacologic-therapies-low-back-pain-systematic-review-american-college